BRIEF-Point72 Asset Management, L.P. Reports 6.2% Passive Stake In ATYR Pharma As Of Oct 14 - SEC Filing-February 2024-www.financetom.com

BRIEF-Point72 Asset Management, L.P. Reports 6.2% Passive Stake In ATYR Pharma As Of Oct 14 - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Point72 Asset Management, L.P. Reports 6.2% Passive Stake In ATYR Pharma As Of Oct 14 - SEC Filing

Oct 17, 2024 1:06 PM

Oct 15 (Reuters) - aTyr Pharma Inc ( ATYR ):

* POINT72 ASSET MANAGEMENT, L.P. REPORTS 6.2% PASSIVE STAKE

ATYR PHARMA AS OF OCT 14 - SEC FILING

Source text for Eikon:

Further company coverage:

Previous page： Embraer says South Africa in talks for purchase of C-390 aircraft Next page： Berkshire sells more BofA shares, netting $9 billion since July

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Embraer says South Africa in talks for purchase of C-390 aircraft

Sep 26, 2024

SAO PAULO (Reuters) - South Africa has advanced in talks for a potential purchase of Embraer's C-390 Millennium, the Brazilian planemaker said on Wednesday, after showcasing the military cargo aircraft in the African nation for the second time. The company voiced optimism about clinching a sale as South African authorities said they were advancing in the necessary steps for the...

Berkshire sells more BofA shares, netting $9 billion since July

Sep 26, 2024

(Reuters) - Warren Buffett's Berkshire Hathaway ( BRK/A ) has offloaded more shares in Bank of America ( BAC ), its latest filing showed on Tuesday, raking in about $9 billion since July. The conglomerate said it sold around 21 million shares between Sept. 20 and Sept. 24 for around $863 million, following sales of about 45.6 million shares in...

Merck's colorectal cancer therapy fails late-stage trial

Sep 26, 2024

Sept 25 (Reuters) - Merck ( MRK ) said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of colorectal cancer. (Reporting by Christy Santhosh; Editing by Varun H K) ...

Intermap Says Team Chosen by National Geospatial-Intelligence Agency for Data Contract

Sep 26, 2024

06:39 AM EDT, 09/25/2024 (MT Newswires) -- Intermap Technologies ( ITMSF ) overnight Tuesday said its team, in partnership with CACI, has been selected by the National Geospatial-Intelligence Agency (NGA) as one of 10 qualified vendors for the Luno A program. The Luno A contract is valued at up to US$290 million over five years. Luno A aims to enhance...